Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to -$106000.0.

  • Silence Therapeutics' Exchange Rate Effect rose 9836.84% to -$106000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $165000.0, marking a year-over-year increase of 10153.92%. This contributed to the annual value of $60000.0 for FY2024, which is 9198.93% down from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Exchange Rate Effect is -$106000.0, which was up 9836.84% from $198000.0 recorded in Q2 2025.
  • Silence Therapeutics' Exchange Rate Effect's 5-year high stood at $5.7 million during Q3 2022, with a 5-year trough of -$6.5 million in Q3 2024.
  • For the 5-year period, Silence Therapeutics' Exchange Rate Effect averaged around -$527537.5, with its median value being -$35000.0 (2024).
  • The largest annual percentage gain for Silence Therapeutics' Exchange Rate Effect in the last 5 years was 678905.4% (2022), contrasted with its biggest fall of 253611.71% (2022).
  • Over the past 5 years, Silence Therapeutics' Exchange Rate Effect (Quarter) stood at -$241293.9 in 2021, then plummeted by 2536.12% to -$6.4 million in 2022, then soared by 37.23% to -$4.0 million in 2023, then surged by 96.02% to -$159000.0 in 2024, then surged by 33.33% to -$106000.0 in 2025.
  • Its last three reported values are -$106000.0 in Q3 2025, $198000.0 for Q2 2025, and $232000.0 during Q1 2025.